BioMarin Pharmaceutical (BMRN) Stock Nɛnɛya
Prévision IA: BMRN
AI bɛ sɔrɔli kɔrɔtɔli sɔrɔ sisan kɔnɔ, kɔnɔ sɔrɔli ni kɔnɔ sɔrɔli. Bɛnɛya bɛ sɔrɔ kɔnɔ sɔrɔli kɔnɔ. O bɛɛ bɛ sɔrɔ ni statistiki, a tɛ jɛya kɔrɔtɔli.
Prix sur les 6 derniers mois
Premium affiche les objectifs de prix de l'IA à 1 jour, 1 semaine et 1 mois pour cette action et toutes les autres.
Débloquer Premium🔒 Nɛnɛya kɔrɔtɔli sɔrɔli
Nɛnɛya kɔrɔtɔli sɔrɔli — nɛnɛya bɛɛ ni kɔnɔ sɔrɔli — bɛ Premium kɔnɔ.
Débloquer PremiumƝɛnɛ kɔnɔ bɛnɛ
BioMarin Pharmaceutical Inc. develops and markets therapeutic enzyme products. The company has applied its proprietary enzyme technology to develop treatments for lysosomal storage diseases and serious burns. BioMarin Pharmaceutical also provides analytical and diagnostic products and services in the field of carbohydrate biology.